Cargando…
New therapeutic targets in the treatment of prostate cancer
Androgen deprivation therapy has become the mainstay of the treatment of advanced prostate cancer, being used in every clinical setting of the disease, from neoadjuvant to metastatic disease. Despite success in controlling the disease in the majority of men, hormonal manipulations will eventually fa...
Autores principales: | Vijjan, Vivek, Dubey, Deepak |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721500/ https://www.ncbi.nlm.nih.gov/pubmed/19675766 http://dx.doi.org/10.4103/0970-1591.30270 |
Ejemplares similares
-
Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008) -
The current role of direct vision internal urethrotomy and self-catheterization for anterior urethral strictures
por: Dubey, Deepak
Publicado: (2011) -
Pathogenesis of prostate cancer and hormone refractory prostate cancer
por: Girling, J. S., et al.
Publicado: (2007) -
Treatment algorithm in hormone-resistant prostate cancer: Practical guidelines
por: Khochikar, Makarand V.
Publicado: (2007) -
BPH and prostate cancer risk
por: Miah, Saiful, et al.
Publicado: (2014)